Clicky

Orthofix International N.V.(OFIX)

Description: Orthofix International N.V., a medical device company, designs, develops, manufactures, markets, and distributes medical equipment used principally by musculoskeletal medical specialists for spine and orthopedic applications. The company operates through two segments, Spine and Orthopedics. It offers spinal implant products, and related human cellular and tissue based products used in surgical procedures; non-invasive regenerative stimulation products for use in bone growth and spinal fusions, and to treat non-union fractures; external and internal fixation devices for use in fracture repair, limb lengthening, and bone reconstruction; and bone cement and devices for removal of bone cement used to fix artificial implants. The company serves hospitals, doctors, and other healthcare providers. Orthofix International N.V. distributes its products directly in the United States, the United Kingdom, Italy, Germany, Switzerland, Austria, France, Belgium, Brazil, and Puerto Rico, as well as through independent distributors, sales representatives, and affiliates in other markets. The company was founded in 1987 and is headquartered in Curacao, the Netherlands Antilles.


Keywords: Medicine Surgery Medical Equipment Healthcare Providers Bone Orthopedic Surgery Spine Orthopedics Stryker Corporation Bone Fracture Spinal Fusion Globus Medical Internal Fixation Orthopedic Applications Bone Cement Spinal Implant Products

Home Page: www.orthofix.com

OFIX Technical Analysis

3451 Plano Parkway
Lewisville, TX 75056
United States
Phone: 214 937 2000


Officers

Name Title
Mr. Jon C. Serbousek Pres, CEO & Director
Mr. Douglas C. Rice CFO & Chief Accounting Officer
Ms. Kimberley A. Elting Chief Legal & Devel. Officer and Pres of the Global Orthopedics
Mr. Kevin J. Kenny Pres of Global Spine Bus.
Mr. Roberto Donadello Sr. VP of Global Operations
Dr. James T. Ryaby B.A., Chemistry, Ph.D. Chief Scientific Officer
Mr. Dan E. Yarbrough VP of Investor Relations
Ms. Suzanne Armstrong Sr. VP of HR
Mr. Ehab M. Esmail Sr. VP of Quality, Regulatory & Clinical Affairs
Mr. Mark Quick Sr. Director of Bus. Devel. & Investor Relations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 60.241
Trailing PE: 0
Price-to-Book MRQ: 1.2204
Price-to-Sales TTM: 0.8815
IPO Date: 1992-04-24
Fiscal Year End: December
Full Time Employees: 1087
Back to stocks